These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35857251)

  • 1. The role of MACF1 on acute myeloid leukemia cell proliferation is involved in Runx2-targeted PI3K/Akt signaling.
    Wang P; Zhang J; Zhang H; Zhang F
    Mol Cell Biochem; 2023 Mar; 478(3):433-441. PubMed ID: 35857251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRRC1 knockdown downregulates MACF1 to inhibit the malignant progression of acute myeloid leukemia by inactivating β-catenin/c-Myc signaling.
    Wang Y; Tong H; Wang J; Hu L; Huang Z
    J Mol Histol; 2024 Feb; 55(1):37-50. PubMed ID: 38165568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-338-3p Plays a Significant Role in Casticin-Induced Suppression of Acute Myeloid Leukemia via Targeting PI3K/Akt Pathway.
    Yu K; Wang J; Hou J; Zhang L; Liang H
    Biomed Res Int; 2022; 2022():9214130. PubMed ID: 35765408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype.
    Liu Y; Chen Y; Liu Y; Li M; Zhang Y; Shi L; Yang L; Li T; Li Y; Jiang Z; Liu Y; Wang C; Wang S
    J Transl Med; 2022 Dec; 20(1):612. PubMed ID: 36550462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of keloids through Runx2 siRNA‑induced inhibition of the PI3K/AKT signaling pathway.
    Lv W; Wu M; Ren Y; Luo X; Hu W; Zhang Q; Wu Y
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia.
    Liang X; Xia R
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34792179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel iheyamine A derivative L42 suppresses acute myeloid leukemia via dual regulation of the PI3K/AKT/FOXO3a axis and TNF signaling pathway.
    Dinghuan W; Yi K; Jianzhi T; Wenfei W; Chunlin W; Anling H; Zhixu H; Ben-David Y; Sheng L; Xiaoyan Y; Xiao X
    Biomed Pharmacother; 2024 Aug; 177():117071. PubMed ID: 38981243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway.
    Cheng J; Li Y; Liu S; Jiang Y; Ma J; Wan L; Li Q; Pang T
    FASEB J; 2019 Apr; 33(4):4755-4764. PubMed ID: 30592634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RUNX2 Plays An Oncogenic Role in Esophageal Carcinoma by Activating the PI3K/AKT and ERK Signaling Pathways.
    Lu H; Jiang T; Ren K; Li ZL; Ren J; Wu G; Han X
    Cell Physiol Biochem; 2018; 49(1):217-225. PubMed ID: 30138923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory role of RBM39 in acute myeloid leukemia: Mediation through the PI3K/AKT pathway.
    Zhang X; Yang L; Liu X; Nie Z; Liu M; Wang T; Lu Y; Pan Y; Zhan Y; Wang Z; Luo J
    Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119607. PubMed ID: 37852323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells.
    Nepstad I; Hatfield KJ; Grønningsæter IS; Reikvam H
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreasing of serine/threonine kinase 39 has tumour inhibiting effects on acute myeloid leukaemia by impacting the PI3K/AKT and Wnt/β-catenin signalling cascades.
    Li C; Xin H; Hao J; Miao Y
    Toxicol Appl Pharmacol; 2024 Aug; 489():116982. PubMed ID: 38821216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody.
    Chapuis N; Tamburini J; Cornillet-Lefebvre P; Gillot L; Bardet V; Willems L; Park S; Green AS; Ifrah N; Dreyfus F; Mayeux P; Lacombe C; Bouscary D
    Haematologica; 2010 Mar; 95(3):415-23. PubMed ID: 20007139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
    Lin X; Xiao Y; Chen Z; Ma J; Qiu W; Zhang K; Xu F; Dang K; Qian A
    Mol Cell Endocrinol; 2019 Aug; 494():110494. PubMed ID: 31260729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway.
    Wang F; Yang L; Xiao M; Zhang Z; Shen J; Anuchapreeda S; Tima S; Chiampanichayakul S; Xiao Z
    Sci Rep; 2022 Jul; 12(1):11444. PubMed ID: 35794161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA‑93 knockdown inhibits acute myeloid leukemia cell growth via inactivating the PI3K/AKT pathway by upregulating DAB2.
    Huang J; Xiao R; Wang X; Khadka B; Fang Z; Yu M; Zhang L; Wu J; Liu J
    Int J Oncol; 2021 Oct; 59(4):. PubMed ID: 34476495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling.
    Pulikkan JA; Madera D; Xue L; Bradley P; Landrette SF; Kuo YH; Abbas S; Zhu LJ; Valk P; Castilla LH
    Blood; 2012 Jul; 120(4):868-79. PubMed ID: 22613795
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Zhao J; Liu J; Liu S; Tian S; Yuan H; Li S
    Epigenomics; 2023 Mar; 15(6):369-383. PubMed ID: 37212125
    [No Abstract]   [Full Text] [Related]  

  • 19. Microtubule actin crosslinking factor 1 promotes osteoblast differentiation by promoting β-catenin/TCF1/Runx2 signaling axis.
    Hu L; Su P; Yin C; Zhang Y; Li R; Yan K; Chen Z; Li D; Zhang G; Wang L; Miao Z; Qian A; Xian CJ
    J Cell Physiol; 2018 Feb; 233(2):1574-1584. PubMed ID: 28621459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia.
    Qu Y; Wang Y; Wang P; Lin N; Yan X; Li Y
    Cell Biol Int; 2020 Aug; 44(8):1745-1759. PubMed ID: 32369230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.